晚发型硬皮病肾危象确实存在:一项多中心研究
这项回顾性观察研究纳入1995至2018年三家大学附属医院诊断的223例硬皮病肾危象(SRC)患者,其中晚发型(系统性硬化症诊断5年后发生)54例(24.2%),平均发生于诊断后12.2年。晚发型组男性比例(59% vs 9%)和激素暴露比例(56% vs 29%)高于早发型组,但两组自身抗体谱和结局无差异证据。
要点
- 晚发型SRC占全部SRC的24.2%(54/223),平均发生于系统性硬化症诊断后12.2年。
- 晚发型组男性比例59% vs 早发型组9%,激素暴露56% vs 29%。
- 两组自身抗体谱和结局无差异证据。
核心结论
- 晚发型SRC见于高达25%的SRC患者,平均发生于系统性硬化症诊断后12年。
- 早发型与晚发型SRC的临床特征和结局相当,作者强调不论疾病病程长短均应识别SRC以优化结局。
研究设计与样本
- 回顾性观察研究,纳入1995至2018年三家大学附属医院诊断的SRC患者。
- 晚发型SRC定义为系统性硬化症诊断5年后发生的SRC。
- 共纳入223例SRC患者,其中早发型169例(75.8%),晚发型54例(24.2%)。
- 连续数据以均值/中位数表示,分类数据以频数/百分比表示,差异采用Pearson卡方检验分析。
主要发现
- 晚发型组SRC平均发生于系统性硬化症诊断后12.2年。
- 晚发型组男性占59%,早发型组男性占9%。
- 晚发型组激素暴露占56%,早发型组占29%。
- 早发型与晚发型组之间自身抗体谱无差异证据。
- 早发型与晚发型组之间结局无差异证据。
临床怎么用
- 作者认为,不论疾病病程长短均应识别SRC以优化结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Scleroderma renal crisis (SRC) is historically described to occur within the first five years of systemic sclerosis (SSc) diagnosis. However, it has been observed to occur beyond five years. In this analysis, we aim to describe the prevalence, clinical features, and outcomes of late-onset SRC and compare them with early-onset SRC. METHODS: This retrospective observational study included patients diagnosed with SRC between 1995 and 2018 at three university-affiliated hospitals. Late-onset SRC was defined as SRC occurring five years after SSc diagnosis. After obtaining institutional review board approval, data including demographics, SRC onset, clinical characteristics, laboratory data, and outcomes were extracted. Continuous data were expressed as mean/median and categorical data as frequencies/percentages. Differences were analyzed via Pearson's chi-square test. RESULTS: A total of 223 patients with SRC were identified, with 169 (75.8%) classified as early onset and 54 (24.2%) as late onset. The late-onset group had a mean SRC onset of 12.2 years after SSc diagnosis. Male predominance was observed in the late-onset compared with the early-onset group (59% vs 9%). Steroid exposure was more common in late vs early group (56% vs 29%). There was no evidence of difference in autoantibodies profile and outcomes between early- and late-onset groups. CONCLUSION: Late-onset SRC was seen in up to 25% of patients with SRC, with a mean of 12 years after SSc diagnosis. Our findings reveal comparable clinical characteristics and outcomes between early- and late-onset SRC, underlying the importance of recognizing SRC regardless of disease duration to optimize outcomes.
引用
- Mehta S, Wajid S, Albaba I, et al. Late-Onset Scleroderma Renal Crisis Does Occur-A Multicenter Study. Arthritis Care Res (Hoboken). 2025. PMID: 40654121. doi:10.1002/acr.25608
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。